A conceptual framework for the diagnostic pathology of anxiety disorders: Clinical and pathological tetrads for identifying pathological anxiety

ABSTRACT

Anxiety disorders (ADs) are among the most prevalent psychiatric conditions and contribute substantially to disability, healthcare burden, and impaired quality of life. However, current diagnostic systems rely primarily on descriptive psychopathology and symptom-based classifications, providing limited guidance for distinguishing adaptive from pathological anxiety during clinical assessment. The aim is to propose a Diagnostic Pathology Framework for ADs that operationalizes the distinction between adaptive and pathological anxiety using clinically identifiable markers. This conceptual paper proposes three interrelated constructs. First, the 3R’s Framework conceptualizes anxiety as the Receipt of stimuli, automatic Reactions, and consciously regulated Responses. Second, anxiety is viewed as an adaptive survival reaction expressed through four domains: worry, fear, arousal, and avoidance. Third, pathological anxiety is operationalized using the Clinical Tetrad comprising Temporal pattern, Intensity, Proportionality, and Controllability (TIP-C) which serves as clinical markers for identifying pathology. Framework characterizes the diagnostic pathology of ADs through a Pathological Tetrad comprising pathological worry, pathological fear, pathological arousal, and pathological avoidance. These are further sub-classified into generalized/focal pathological worry, interoceptive/exteroceptive pathological fear, tonic/phasic pathological arousal, and in-situ/ex-situ pathological avoidance. Clinical Tetrad operationalizes the identification of Pathological Anxiety (PA), while the Pathological Tetrad characterizes its principal manifestations across ADs. The proposed Framework complements descriptive psychopathology by introducing operational clinical markers for identifying PA. By integrating TIP-C Clinical Tetrad with the Pathological Tetrad, it provides a clinicopathological approach that may enhance diagnostic reasoning, medical education, and future research. Further studies are required to establish its reliability, validity, and clinical utility across diverse clinical settings.

INTRODUCTION

Anxiety is a universal human experience across ages, cultures, and backgrounds. In simple, anxiety is an uneasy experience often arising from perceived threat and may be understood as a form of mental pain, analogous to physical pain, that signals distress and mobilizes adaptive responses.[1,2] This aligns with “psychache,” or psychological pain resulting from unmet needs, internal conflict, or perceived threats to the self.[3]

Anxiety disorders (ADs) are among the most prevalent psychiatric conditions worldwide, contributing substantially to disability, impaired quality of life, healthcare burden, and socioeconomic costs through reduced productivity, absenteeism, and presenteeism.[4,5,6,7,8] They are commonly encountered in primary care, tertiary psychiatric services, and medical and surgical specialties.[9,10,11]

Despite their importance, AD diagnosis relies largely on symptom-based systems, including the International Classification of Diseases (ICD) and the Diagnostic and Statistical Manual of Mental Disorders (DSM).[12,13] Although these systems improve reliability, they provide limited operational guidance on when adaptive anxiety becomes pathological anxiety (PA). This limitation may contribute to symptom overlap, comorbidity, and diagnostic inflation.[14,15]

Cognitive, stress-appraisal, emotion-regulation, affective-neuroscience, and phenomenological models have advanced understanding of anxiety. They explain maladaptive information processing, appraisal of demands and coping resources, regulatory failure, neural-circuit dysfunction, and subjective experience.[16,17,18,19,20] However, their translation into routine diagnostic decision-making remains limited.

Descriptive (psycho)pathology, a well-established approach in both classical and contemporary psychiatric literature, refers to the systematic phenomenological description of psychiatric symptoms and signs without necessarily incorporating clinical judgment, etiological interpretation, or explicit diagnostic thresholds.[20] While descriptive psychiatry organizes these phenomena into clinically recognizable syndromes and diagnostic categories, it does not explicitly define the pathological markers that distinguish normal from disordered anxiety.[21,22,23] Thus, while descriptive psychopathology focuses on the what of mental phenomena, descriptive psychiatry addresses the organisation of these phenomena into clinically recognizable syndromes and diagnostic categories. Notably, widely used psychopathology texts focus predominantly on symptom description, with limited attention to operational clinical markers of psychiatric disorders, including ADs.[24,25,26,27] Although pathological anxiety (PA) is typically considered excessive, persistent, disproportionate, poorly controllable, distressing, or impairing, these dimensions are often implicit within current frameworks.[1,28] This gap supports the need for an integrative clinicopathological framework for ADs.

To address this gap, the author introduces the concept of diagnostic pathology in psychiatry, analogous to diagnostic pathology in general medicine.[29] The proposed Diagnostic Pathology framework applies a clinicopathological approach to ADs. Whereas medical diagnosis may draw on signs, laboratory tests, imaging, physiology, microbiology, and histopathology, psychiatric diagnosis relies mainly on systematically elicited pathological findings. TIP-C clinical markers operationalize identification of PA, while the Pathological Tetrad describes its main manifestations. Diagnostic Pathology is therefore a clinicopathological concept, not biological: it identifies clinically meaningful markers that distinguish adaptive anxiety from PA and support structured diagnostic reasoning, without implying histopathological abnormalities in ADs.

CONCEPTUAL DEVELOPMENT

The conceptual development of the proposed Diagnostic Pathology Framework is described by first outlining the rationale for the framework and then examining its relationship to existing diagnostic systems and theoretical models of ADs. As this is a conceptual/theoretical paper, ethics committee approval was not required.

Rationale for the Proposed Diagnostic Pathology Framework

Despite substantial advances in the understanding and classification of ADs, an important gap remains between descriptive symptom assessment and clinical diagnostic reasoning. Contemporary diagnostic systems, including the DSM-5-TR and ICD-11, provide standardized diagnostic criteria that improve reliability but primarily focus on categorical classification after symptom thresholds are met.[12,13] Likewise, cognitive, neurobiological, and phenomenological models have considerably advanced the understanding of anxiety mechanisms but are not designed as operational tools for determining when normal or adaptive anxiety becomes pathological in routine clinical practice.[16,20,30] Consequently, physicians often rely on implicit clinical judgment to distinguish adaptive anxiety from ADs. This highlights the need for a structured clinicopathological framework that operationalizes the identification of PA through clinically elicitable markers, thereby providing a transparent and reproducible pathway from symptom evaluation to diagnostic formulation. Figure 1 depicts the Diagnostic Pathway in Anxiety Disorders by comparing Between Conventional Symptom-Based Diagnosis and the Proposed Diagnostic Pathology Framework.

Figure 1.

Diagnostic pathway in anxiety disorders: Comparison between conventional symptom-based diagnosis and the proposed diagnostic pathology framework

The author outlines three interrelated concepts forming the proposed Diagnostic Pathology Framework for ADs.

I. From Receipt to Reaction and Response: A 3R’s Framework of Anxiety

For conceptual clarity, anxiety is conceptualized as a sequence of three processes: Receipt, Reaction, and Response (3R’s). Receipt refers to the perception and appraisal of internal or external stimuli through senses, thoughts, memories, or bodily sensations that may signal threat or challenge.[17,31] Reaction refers to the immediate and largely automatic emotional (fear), cognitive (worry), physiological (arousal), and behavioral (avoidance) changes triggered by the stimulus, serving adaptive survival functions.[32,33] Response refers to conscious, reflective, and goal-directed processes involving appraisal, reasoning, emotional regulation, and behavioral choice that enable flexible adaptation to environmental demands.[34,35]

From a clinical perspective, adaptive functioning depends on the ability to regulate anxiety reactions and generate appropriate responses. ADs may therefore be conceptualized as conditions in which anxiety reactions become excessive, persistent, disproportionate, or difficult to control, impairing adaptive functioning.

II. Expression of Anxiety as an Adaptive Survival Reaction

From an evolutionary perspective, anxiety is a fundamental survival reaction rather than an inherently undesirable experience. It enables individuals to detect, anticipate, and respond to potential threats. Following exposure to a stressor, adaptive changes occur during the period of adaptation in both body and mind to preserve homeostasis; once the threat resolves, these reactions subside and baseline functioning is restored.[36,37]

Anxiety reactions are expressed across four interrelated domains: fear (emotional), worry (cognitive), arousal (physiological), and avoidance (behavioral). These reactions facilitate survival by enabling —fear enables rapid emotional reactions to immediate threats; worry supports anticipation and planning; arousal prepares the organism for action, and avoidance reduces exposure to harm. Moderate anxiety functions as an adaptive warning system that promotes learning, performance, and coping. However, when these reactions become excessive, persistent, disproportionate, or dysregulated, they contribute to the clinical manifestations of ADs. Thus, maladaptive/pathological anxiety may be understood as a distortion of otherwise adaptive survival mechanisms.

III. Clinical Markers of Anxiety Disorders: Defining Pathological Anxiety with Four Elicitable Signs (Clinical Tetrad)

Anxiety reactions are not inherently pathological. Anxiety becomes maladaptive/pathological when it is recurrent or persistent, excessive in intensity, disproportionate to context, and associated with impaired control over its experience. PA is predominantly a quantitative rather than qualitative extension of adaptive anxiety.[38] The characteristics of PA are not explicitly defined in literature.

There is no universally standardized definitions of symptoms and signs in medicine, and the terms are often used interchangeably—particularly in psychiatry. Broadly, symptoms generally refer to subjective experiences reported by patients, whereas signs refer to observable, elicitable, or inferable phenomena identified during clinical assessment by physicians, or even by caregivers and patients themselves.[39,40] In this manuscript, the term sign is used broadly to include observable, elicitable, and inferred clinical phenomena. When overlap exists between symptoms and signs—such as tremor or skin lesions—priority is given to signs.

In general medicine, diagnosis is often supported by clinical markers—objective, measurable signs that reflect underlying physiological or pathological processes. These markers, such as pulse rate, blood pressure, laboratory findings, and imaging abnormalities, help physicians identify disease, determine severity, monitor progression, and evaluate treatment response.[29,41,42]

Analogously, the author proposes four clinical markers/signs for ADs: Temporal pattern, Intensity, Proportionality, and Controllability (TIP-C). Applied across the core anxiety reactions of fear, worry, arousal, and avoidance, these markers function as clinically elicitable indicators that distinguish adaptive from PA. Together, they constitute a clinical tetrad (TIP-C) and act as operational clinical markers of pathology of ADs. When applied to the four pathological manifestations of anxiety—pathological worry, pathological fear, pathological arousal, and pathological avoidance—they generate a complementary pathological tetrad. Thus, the framework consists of two interconnected tetrads: a clinical tetrad that identifies pathology and pathological tetrad that characterizes its expression.

Temporal pattern refers to the longitudinal course of anxiety reactions and may be persistent or recurrent. Assessment focuses on duration, recurrence, persistence beyond the precipitating stressor, and interference with return to baseline functioning. Adaptive anxiety is typically transient, whereas PA persists beyond the expected period of adaptation or recurs repeatedly over time.

Intensity refers to the magnitude of the anxiety reaction. Adaptive anxiety is generally mild to moderate and facilitates coping, whereas PA is excessive, overwhelming, and greater than expected for the situation.

Proportionality reflects the degree of match between the anxiety reaction and the actual or perceived threat. It encompasses appropriateness, rationality, and reasonability of the reaction. Physicians should evaluate the objective threat level, consistency between perceived and actual danger, cultural and developmental appropriateness, and reactions of individuals facing similar circumstances. Adaptive anxiety is proportionate to realistic demands, whereas PA is disproportionate to the objective risk or context.

Controllability refers to the individual’s ability to regulate anxiety reactions, including control over onset, intensity, termination, and cognitive engagement. Adaptive anxiety can usually be modified through reassurance, coping strategies (problem-solving), or voluntary effort, whereas PA is characterized by diminished control and persistence despite repeated attempts at regulation.

Collectively, these clinical markers help identify the threshold at which adaptive anxiety transitions into PA. Their interpretation should consider relevant sociocultural factors, including age and gender.

RESULTS AND DISCUSSION

Diagnostic pathology of anxiety disorders: Four clinical forms (pathological tetrad) of pathological anxiety

The diagnostic pathology of ADs can be conceptualized as four pathological manifestations of adaptive anxiety reactions: pathological worry, pathological fear, pathological arousal, and pathological avoidance. Together, these constitute the pathological tetrad of ADs. The distinction between adaptive and pathological anxiety within each domain is determined using the TIP-C clinical tetrad/markers/signs identified during clinical assessment.

A. Pathological Worry

Worry is a future-oriented cognitive process that facilitates anticipation, planning, and problem-solving. It becomes pathological when it is persistent or recurrent, excessive, difficult to control, and disproportionate to actual or anticipated stressors.[1]

Based on its distribution across life domains, pathological worry may be classified into two subtypes:

1. Generalized (Diffuse) Pathological Worry – involves multiple domains such as work, family, health, finances, or safety concerns. It is often free-floating and may shift between stressors, as commonly observed in generalized anxiety disorder (GAD).

2. Focal (Specific/Localized/Circumscribed) Pathological Worry – restricted to a particular situation or domain and usually centred on a dominant theme. Examples include evaluative worry in social anxiety disorder, catastrophic worry in panic disorder, object- or situation-specific worry in specific phobia, and escape-related worry in agoraphobia.

B. Pathological Fear

Fear is an immediate emotional reaction to perceived or imminent threat that normally serves a protective function (adaptive). It becomes pathological when it is persistent or recurrent, excessive, disproportionate to the actual threat, or difficult to control.

Based on the source of the perceived threat, pathological fear may be classified into two subtypes:

1. Interoceptive Pathological Fear (Panic-Type) –catastrophic fear arising in the absence of an external stimulus. It is typically spontaneous, internally generated, and often unpredictable, frequently originating from interoceptive bodily sensations such as palpitations, dizziness, or breathlessness. These sensations trigger a first-order fear (triggered by internal bodily sensations), which is subsequently catastrophically misinterpreted, leading to a second-order fear (e.g., “I am going to die” or “I am losing control”). This escalation culminates in the cycle of “fear of fear” phenomenon and manifests clinically as typical panic attacks.[1,43,44]

2. Exteroceptive Pathological Fear (Phobic-Type) – exaggerated fear directed toward identifiable external stimuli such as animals, heights, needles, social situations, or enclosed spaces. It is typically stimulus-bound, predictable, and often associated with localized pathological worry (anticipatory anxiety), panic-like arousal (atypical panic attack), and pathological avoidant behavior.[34]

C. Pathological Arousal

Arousal refers to increased physical and mental (mind) alertness resulting from activation of the central and autonomic nervous systems. While adaptive arousal prepares the individual for effective action, pathological arousal is characterized by excessive, persistent or recurrent, disproportionate, and poorly controllable activation (TIP-C).

Pathological arousal may arise from elevated baseline activation, lowered activation thresholds, or delayed recovery following activation, resulting in sustained physiological dysregulation.[1] Table 1 summarizes predominant clinical features of pathological arousal.

Table 1.

Predominant clinical signs of pathological arousal

Phasic (Episodic) Pathological Arousal	Tonic (Persistent) Pathological Arousal
Predominantly ANS arousal	Predominantly CNS arousal
I. Physical  Neuro (Motor and vestibular)   • Trembling/shaking/muscular tension   • Dizziness/light-headedness/Fainting/unsteadiness  Cardiovascular   • Tachycardia/Palpitations   • Chest pain/discomfort   • Elevated blood pressure   • Cold or clammy skin (vasomotor reaction)  Respiratory   • Tachypnoea   • Dyspnoea   • Choking  Gastrointestinal   • Epigastric discomfort/nausea/vomiting/diarrhoea   • Reduced digestion/gut shutdown/butterfly in stomach (in children)   • Dry mouth  Autonomic–Cutaneous   • Hyperhidrosis   • Blushing (Social phobia)  Ocular/Autonomic   • Mydriasis   • Sweating   • Frequency of micturition/incontinence/diarrhoea II. Cognitive   • Fear of going mad/losing control/dying III. Behavioural   • Freezing/unresponsive episodes	Cognitive–Emotional Domain (Predominant Features)   • Hypervigilance (excessive monitoring for threat-related or negative information, including adverse news)   • Heightened cognitive alertness   • Increased startle reaction   • Threat anticipation (“something bad might happen”)   • Difficulty concentrating/Cognitive fatigue   • Mind going blank/overthinking/restless mind   • Irritability/anger/tension Sleep Disturbance   • Initial insomnia   • Maintenance insomnia   • Non-restorative/non-refreshing sleep Neuro (Motor and Muscle Tension)   • Restlessness/feeling “on edge”   • Inability to relax   • Easily fatigued   • Trembling   • Tension headaches/light-headedness   • Fidgeting

Based on temporal pattern, pathological arousal may be classified into two subtypes:

1. Tonic Pathological Arousal – sustained physiological and cognitive activation lasting weeks or longer (persistent), typically characterized by hypervigilance, excessive worry, muscle tension, restlessness, anticipatory tension, and sleep disturbance. This pattern is commonly observed in GAD.

2. Phasic Pathological Arousal – brief episodes (Episodic/Recurrent) of intense autonomic activation occurring with relatively symptom-free intervals, as seen in panic attacks. These episodes are characterized by sudden onset, rapid escalation, autonomic symptoms, and intense fear of dying, losing control, or future attacks.

D. Pathological Avoidance

Avoidance refers to behavioral or cognitive efforts to evade perceived threats or distress. Although adaptive avoidance protects individuals from genuine danger, pathological avoidance is excessive, persistent or recurrent, disproportionate, and difficult to control. By preventing corrective learning and coping, it contributes to the maintenance of anxiety.[45]

Based on the timing and degree of exposure to the feared stimulus, pathological avoidance may be classified into two subtypes:

1. Ex-Situ (Pre-Exposure/Complete) Pathological Avoidance (avoidance before exposure) refers to avoidance occurring before or outside the exposure to the anxiety-provoking situations, achieved by preventing or escaping exposure to the feared situation altogether. These include active avoidance (e.g., avoiding social gatherings, cancelling flights, or taking alternative routes to avoid feared situations) and passive avoidance (e.g., not applying for jobs, avoiding important conversations, or not attending work or classes despite capability).

2. In-Situ (In-Exposure/Partial) Pathological Avoidance (avoidance during exposure) refers to avoidance behaviours occurring after exposure has begun, while the individual remains within the anxiety-provoking situation, allowing only partial engagement. These include safety behaviors (e.g., overpreparing speeches, limiting eye contact, carrying medications or water bottles, reassurance seeking, etc), attentional strategies (e.g., distracting oneself with a phone, suppressing anxious thoughts, monitoring heart rate or breathing), and situational modifications (e.g., attending events only with trusted companions, standing near exits, or keeping escape options readily available). Although exposure occurs, these strategies reduce emotional processing and corrective learning, thereby maintaining anxiety over time.

Both forms maintain anxiety through negative reinforcement, differing primarily in the degree of exposure to the feared stimulus.

Future directions

The proposed Diagnostic Pathology Framework requires empirical validation before routine clinical adoption. Research should assess inter-rater reliability of the TIP-C clinical markers and Pathological Tetrad across clinicians and settings. Studies should establish construct, convergent, and discriminant validity, including comparisons with established anxiety measures and related psychiatric conditions. Predictive validity should examine diagnostic outcomes, illness course, and treatment response. Comparisons with DSM-5-TR and ICD-11 should assess diagnostic agreement and incremental utility. Developing and validating a structured clinical interview would support standardized assessment. Longitudinal and treatment studies should evaluate temporal stability, diagnostic progression, and responsiveness to pharmacological and non-pharmacological interventions.

CONCLUSION

This manuscript proposes a Diagnostic Pathology Framework for ADs that links descriptive psychopathology with diagnostic decision-making. It operationalizes PA using clinical tetrad/markers and the Pathological Tetrad: pathological worry, fear, arousal, and avoidance. The framework distinguishes adaptive anxiety from PA and supports structured clinical reasoning. It complements, rather than replaces, DSM-5-TR and ICD-11 by identifying PA before categorical diagnosis. If validated, it may improve diagnostic consistency, education, clinician communication, and research on AD assessment and treatment. Further studies should establish its reliability, validity, clinical utility, and generalizability.

Conflicts of interest

There are no conflicts of interest.

Funding Statement

Nil.